aod9604 clinical trials side effects AOD-9604 Clinical Trial Results &

Not medical advice This information is not a substitute for professional medical guidance, diagnosis, or treatment

AOD 9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (GH fragment 176191), structurally modified with an N-terminal tyrosine residue to enhance stability in experimental systems

Fatigue is usually the first red flag

AOD-9604 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use

It also aids DNA repair, stress responses, inflammation control, and sirtuin function.[2] Insufficient NAD+ hampers cellular functions critical for vitality

While some people may experience noticeable benefits from MIC B12 injections, results can vary